Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Human LRP4 Antibodies:
anti-Mouse (Murine) LRP4 Antibodies:
anti-Rat (Rattus) LRP4 Antibodies:
Go to our pre-filtered search.
Human Monoclonal LRP4 Primary Antibody for ICC, IF - ABIN2483384
Bennett, Baines: Spectrin and ankyrin-based pathways: metazoan inventions for integrating cells into tissues. in Physiological reviews 2001
Cow (Bovine) Polyclonal LRP4 Primary Antibody for EIA, IHC (p) - ABIN375019
Sagare, Deane, Bell, Johnson, Hamm, Pendu, Marky, Lenting, Wu, Zarcone, Goate, Mayo, Perlmutter, Coma, Zhong, Zlokovic: Clearance of amyloid-beta by circulating lipoprotein receptors. in Nature medicine 2007
the first evidence suggesting that LRP4 is responsible for the retention of sclerostin (show SOST Antibodies) in the bone environment in humans.
study presents 2 sibling fetuses with a prenatal lethal presentation of mesomelic limb reductions, oligosyndactyly, genitourinary malformation and compound heterozygosity for 2 novel truncating mutations in LRP4
MuSK (show MUSK Antibodies) myasthenia gravis IgG4 disrupts the interaction of LRP4 with MuSK (show MUSK Antibodies) but both IgG4 and IgG1-3 can disperse preformed agrin (show AGRN Antibodies)-independent AChR clusters
LRP4 is essential for maintaining the structural and functional activity of the neuromuscular junction.
LRP4 is a new CMS (show Cd2ap Antibodies) disease gene and the 3rd beta propeller domain of LRP4 mediates two signaling pathways in a position-specific manner.
[review] Autoantibodies against LRP4 differentially alter neuromuscular transmission, demonstrating how myasthenia gravis can be classified according to the profile of the antibodies; management of myasthenia gravis patients can be adapted accordingly.
pathogenic IgG4 antibodies to MuSK (show MUSK Antibodies) bind to a structural epitope in the first Ig-like domain of MuSK (show MUSK Antibodies), prevent binding between MuSK (show MUSK Antibodies) and Lrp4, and inhibit Agrin (show AGRN Antibodies)-stimulated MuSK (show MUSK Antibodies) phosphorylation.
Cenani-Lenz syndrome in a large Pakistani pedigree is associated with a novel LRP4 missense mutation.
Data conclude that common variation in the LRP4 gene determines hip and whole body BMD (show BEST1 Antibodies)
The roles of LRP4 in muscle fibers and motoneurons in neuromuscular junction formation have been dissected by cell-specific mutation.
identification of a doublet mutation in complete linkage disequilibrium with syndactyly in one gene of the critical interval: LRP4
autosomal recessive loss-of-function mutations in Megf7/Lrp4 result in a form of syndactyly, mulefoot disease
4 new LRP4 non-synonymous missense point mutations co-segregating in Holstein, German Simmental & Simmental-Charolais families represent independent mutations affecting different conserved protein domains.
We show that prepatterning in mice requires Lrp4 (show CORIN Antibodies) but not the MuSK (show MUSK Antibodies) Fz-like domain
The loss of low density lipoprotein receptor-related protein 4 (show CORIN Antibodies) compromised foetal swallowing and breathing-like movements and downregulated the expression of aquaporin-9 (show AQP9 Antibodies) in the foetal membrane and aquaporin-1 (show AQP1 Antibodies) in the placenta, which possibly affected the amniotic fluid clearance.
Reveal novel roles for APP (show APP Antibodies) in regulating neuromuscular synapse formation through hetero-oligomeric interaction with LRP4 (show CORIN Antibodies) and agrin (show AGRN Antibodies) and thereby provide new insights into the molecular mechanisms that govern NMJ formation and maintenance.
Results suggest that mdig may contribute to silica-induced lung fibrosis by altering the balance between Th17 and Treg cells.
These studies demonstrate a role for Lrp4 (show CORIN Antibodies) in hippocampal function.
Lrp4 (show CORIN Antibodies) is a critical player in bone-mass homeostasis.
Data indicate that LRP4 (low-density lipoprotein receptor-related protein 4 (show CORIN Antibodies)) deficiency in bone dramatically elevated serum sclerostin (show SOST Antibodies) levels whereas bone expression of Sost (show SOST Antibodies) encoding for sclerostin (show SOST Antibodies) was unaltered.
found by laser capture microdissection that LRP4 (show CORIN Antibodies) expression was induced during chondrocyte differentiation in the growth plate
pathogenic IgG4 antibodies to MuSK (show MUSK Antibodies) bind to a structural epitope in the first Ig-like domain of MuSK (show MUSK Antibodies), prevent binding between MuSK (show MUSK Antibodies) and Lrp4 (show CORIN Antibodies), and inhibit Agrin (show AGRN Antibodies)-stimulated MuSK (show MUSK Antibodies) phosphorylation.
Mice immunized with the extracellular domain of LRP4 (show CORIN Antibodies) generated anti-LRP4 (show CORIN Antibodies) antibodies & exhibited myasthenia-gravis-associated symptoms & neuromuscular junction abnormality. LRP4 (show CORIN Antibodies) contributes to neuromuscular junction maintenance in adulthood.
This gene encodes a member of the low-density lipoprotein receptor-related protein family. The encoded protein may be a regulator of Wnt signaling. Mutations in this gene are associated with Cenani-Lenz syndrome.
low density lipoprotein receptor-related protein 4
, low density lipoprotein receptor-related protein 4-like
, low-density lipoprotein receptor-related protein 4-like
, low-density lipoprotein receptor-related protein 4
, multiple epidermal growth factor-like domains 7
, LDLR dan